Nature’s Sunshine announced its financial results for the first quarter of 2025. Net sales during the quarter grew by 2% to $113.2 million with an adjusted EBITDA of $11 million, a 20% increase. The company attributed this EBITDA increase primarily to the boost in net sales. Gross profit margin increased slightly to 72.1% in the quarter, from 71.2% the same period in 2024. Operating income increased to $6.2 million from $4.6 million in the first quarter of last year.
“2025 got off to a strong start, as first quarter revenue came in at $113 million, up 5% on a constant currency basis, and adjusted EBITDA came in at $11 million, up 20% versus prior year,” said Terrence Moorehead, Nature’s Sunshine CEO. “We’re particularly pleased with the exceptional growth we’re seeing in Asia and Europe where markets like Taiwan, Japan and Central Europe continue to deliver strong double-digit growth. We’re also pleased to see early signs of stabilization in North America and continued improvements to gross margin. Despite the tremendous amount of uncertainty in the market, we remain confident in the underlying health of our business, and our performance reflects the power of our global growth strategies. In addition, our board has authorized the repurchase of up to $25 million in common stock, supplementing the $8.3 million remaining under the current authorization, as we continue to make disciplined investments with the highest potential return for our shareholders.”
The company ended the quarter with net cash provided by operating activities of $2.6 million, an increase from $2.2 million in the first quarter of 2024. Cash and cash equivalents at the end of the quarter totaled $86.5 million with no debt.
